List view / Grid view
18 July 2019 | By Victoria Rees (European Pharmaceutical Review)
An Indian pharmaceutical company was planning to shred quality control records ahead of an FDA inspection, found officials.
18 July 2019 | By European Pharmaceutical Review
A new drug delivery system disguises chemo-therapeutics as fat in order to destroy tumours.
17 July 2019 | By Watson-Marlow Fluid Technology Group
Quantum pump specified for critical UF/DF processes; user says “no other pump could meet all of our needs".
17 July 2019 | By European Pharmaceutical Review
A new report shows that there is still a lack of female representation within the senior roles of the major pharmaceutical companies.
16 July 2019 | By European Pharmaceutical Review
AstraZeneca has been issued with a complete response letter for Farxiga by the FDA meaning that it has rejected the treatment.
16 July 2019 | By European Pharmaceutical Review
The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.
16 July 2019 | By Victoria Rees (European Pharmaceutical Review)
Altaire Pharmaceuticals has announced a recall of 31 products due to a lack of sterility assurance from their manufacturing facility.
15 July 2019 | By Victoria Rees (European Pharmaceutical Review)
A medical centre in Hong Kong had 76 boxes of an HPV vaccine seized after a complaint from a patient who experienced adverse side effects.
15 July 2019 | By Victoria Rees (European Pharmaceutical Review)
Amgen has successfully blocked the manufacture, sales and marketing of its Sanofi drug rival in Germany.
15 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The FDA has announced Orphan Drug Designation for Imfinzi (durvalumab) to treat small cell lung cancer in combination with other therapies.
14 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The global controlled release drug delivery market will be worth an estimated $91.2 billion by 2026, according to a new study.
13 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The FDA has released draft guidance for using the Inactive Ingredients Database to aid drug developers.
12 July 2019 | By Victoria Rees (European Pharmaceutical Review)
NICE has issued a recommendation for risankizumab to treat patients with severe plaque psoriasis.
12 July 2019 | By Victoria Rees (European Pharmaceutical Review)
A pharmaceutical manufacturing site in New Jersey receives FDA warning letter for failing to thoroughly investigate quality problems and data integrity issues.
12 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The FDA and EMA have agreed to rely on each other’s assessment of pharmaceutical manufacturing sites to reduce duplicative work.
Follow: